Cochlear implant after Gamma Knife for vestibular schwannoma
Part of Brain & nervous system, Cancer, Ear, nose & throat clinical trials.
This pilot study looks at how well cochlear implants work for hearing restoration in people who previously received Gamma Knife treatment for a tumor called vestibular schwannoma. It may help doctors understand what hearing results to expect after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You previously had Gamma Knife radiosurgery for vestibular schwannoma
- You are interested in getting a cochlear implant to improve your hearing
- You are willing to take part in the study and follow study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special hearing test done during surgery for vestibular schwannoma to help decide what hearing treatment you need afterward. It may help guide whether a cochlear implant is a good option for hearing rehabilitation.
This study looks at how balance and inner-ear (vestibular) function change after Gamma Knife radiosurgery for vestibular schwannoma. It may help doctors understand what to expect during recovery and how well these functions improve.
This study looks at how your balance might change after gamma-knife radiosurgery for a vestibular schwannoma. You will have follow-up balance tests to see if the treatment affects your balance over time.
This study looks at how targeted brain/skull-base treatment for a vestibular schwannoma may affect hearing (ear “ototoxicity,” meaning damage to hearing). It may help doctors better predict and prevent hearing problems in people treated for this tumor.
This trial tests whether physical therapy focused on balance and dizziness before surgery or targeted radiation (SRS) can improve how people with vestibular schwannoma (an acoustic tumor) feel and function. It aims to help prepare your balance system before treatment begins.
This trial tests a gene therapy injected into the ear to slow tumor growth and prevent further hearing loss in people with a vestibular schwannoma that is getting worse. It's for those who already have severe hearing loss in the affected ear.
Hear when a new Vestibular Schwannoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.